
|Articles|January 2, 2005
- Pharmaceutical Technology-01-02-2005
- Volume 29
- Issue 1
Drug Safety and Access Top Policy Concerns for 2005
Author(s)Jill Wechsler
Safety issues and shortages may slow down new drug development and FDA reforms
Advertisement
Articles in this issue
about 21 years ago
An Overview of the Effect of Moisture on Compaction and Compressionabout 21 years ago
The Pipeline Crisisabout 21 years ago
The Outsourcing Advantages in Formulation Developmentabout 21 years ago
Comparison of EP "Heavy Metals" Test with USP "Conductivity" Testabout 21 years ago
Patheon Places Big Bet with Mova Acquisitionabout 21 years ago
January 2005about 21 years ago
In the Spotlight-January 2005Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Grants Priority Review to AZ's Datroway for Metastatic Triple Negative Breast Cancer
2
Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D
3
FDA Launches PreCheck Pilot Program to Bolster Domestic Drug Manufacturing
4
Behind the Headlines Episode 32: AI’s Power, NVIDIA & Lilly, Revolution Medicine
5




